Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Levi Strauss Co Seeks 10Year Extension for Levis Stadium Naming Rights

Elaine Mendonca by Elaine Mendonca
January 25, 2024
in Breaking News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On January 25, 2024, a groundbreaking proposal was put forth by Levi Strauss & Co. that could forever change the landscape of Levi’s Stadium. In an unprecedented move, the renowned company has requested a remarkable 10-year extension for the naming rights, valued at an astounding $170 million. Collaborating with the esteemed San Francisco 49ers, this visionary partnership aims to solidify Levi’s as the stadium’s namesake for an impressive duration, extending all the way until 2043.

This momentous agreement not only demonstrates Levi’s unwavering dedication to the Bay Area but also serves as a resounding testament to their enduring alliance with the 49ers. Such a remarkable commitment signifies the profound impact that Levi Strauss & Co. envisions for the future of both the stadium and their fruitful partnership.

LEVI Stock Performance on January 25, 2024: Mixed Results with After-Hours Decline

LEVI Stock Performance on January 25, 2024:

Price Momentum:
LEVI was observed to be trading in the middle of its 52-week range, indicating a relatively stable position for the stock. The stock was also trading above its 200-day simple moving average, suggesting a bullish sentiment in the market.

Price Change:
The price of LEVI shares experienced a slight increase of $0.03 since the market last closed on January 25, 2024, representing a rise of 0.19%.

After-Hours Trading:
The stock encountered a drop of $0.25 in after-hours trading, implying a decrease of approximately 1.59% from the closing price of $15.75.

Overall, the performance of LEVI stock on January 25, 2024, exhibited mixed results, with a slight increase during regular trading hours but a decline in after-hours trading. It is important to consider the reasons behind the after-hours drop and analyze various factors before making investment decisions.

Levi Strauss & Co. (LEVI) Reports Impressive Revenue Growth and Increased Profitability in 2024

On January 25, 2024, Levi Strauss & Co. (LEVI) experienced a significant boost in its stock performance, driven by impressive revenue growth. According to data sourced from CNN Money, the company reported total revenue of $6.17 billion for the past year, an increase of 6.96% compared to the previous year. Furthermore, the total revenue for the third quarter of the same year stood at $1.51 billion, reflecting a remarkable growth of 13.14% since the previous quarter.

While the revenue growth has been impressive, LEVI’s net income has held flat since last year, standing at $569.10 million. However, the company experienced a remarkable increase of 700.0% in net income since the previous quarter, reaching $9.60 million.

Earnings per share (EPS) is another important metric that investors closely monitor. LEVI reported an EPS of $1.41 for the past year, marking a 4.32% increase compared to the previous year. However, the most notable increase was seen in the third quarter, with an EPS of $0.02, reflecting a staggering growth of 697.5% since the previous quarter.

The strong financial performance of LEVI has undoubtedly contributed to the positive movement of its stock on January 25, 2024. Investors have reacted positively to the company’s impressive revenue growth, as well as the substantial increases in net income and EPS.

Moreover, LEVI’s strong brand recognition and customer loyalty have played a crucial role in driving its revenue growth. The company’s commitment to quality products, innovative designs, and sustainable practices has resonated well with consumers, leading to increased sales and market share.

Overall, LEVI’s stock performance on January 25, 2024, reflects the company’s strong financial performance, driven by robust revenue growth and improved profitability. As LEVI continues to expand its customer base and enhance its operational efficiency, it is well-positioned for further success in the future. Investors can expect LEVI’s stock to remain attractive, given the company’s ability to deliver consistent growth and generate value for its shareholders.

Tags: LEVI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Transportation Stock Bull Market

Rail Visions Main Line System Achieves EU Railway Standards Approval and Certifications

Technology Quantum computing Market Capitalization

Xerox Faces Sales Decline and Disappointing Earnings in Fourth Quarter 2024

Finance_Commercial

Bank of America Securities Analyst Downgrades Boeing Amidst FAAMandated Freeze

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com